John F. Crowley

Chief Executive Officer, Amicus Therapeutics.

Companies

Amicus TherapeuticsChair Mar 3, 2010 to Mar 15, 2024¹
Intellia TherapeuticsBoard member Oct 5, 2020 to Jun 16, 2023²
Entrada Therapeutics, Inc.Board member Oct 28, 2021 to Jun 12, 2023³
Amicus TherapeuticsChief executive officer May 30, 2007 to Jul 19, 2022⁴
Amicus TherapeuticsPresident May 30, 2007 to Feb 3, 2011⁴
Amicus TherapeuticsBoard member May 30, 2007 to Nov 17, 2009⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Entrada Therapeutics, Inc. TRDA37,864 shares⁵$182.1K at $4.81Jan 13, 2022
Intellia Therapeutics NTLA11,716 shares⁶$134.5K at $11.48Jun 14, 2023
Amicus Therapeutics FOLD638,373 shares⁷Mar 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 1, 2024Sold 29,181 shares at $13.35 of Amicus Therapeutics⁷
Feb 15, 2024Shares withheld for tax 94,969 shares at $14.00 of Amicus Therapeutics⁸
Feb 15, 2024Sold 31,614 shares at $13.81 of Amicus Therapeutics⁸
Feb 1, 2024Shares withheld for tax 21,596 shares at $12.67 of Amicus Therapeutics⁹
Feb 1, 2024Sold 31,614 shares at $12.62 of Amicus Therapeutics⁹
Jan 22, 2024Sold 55,327 shares at $12.36 of Amicus Therapeutics¹⁰
Jan 16, 2024Sold 31,614 shares at $12.78 of Amicus Therapeutics¹¹
Jan 10, 2024Sold 31,614 shares at $13.65 of Amicus Therapeutics¹²
Jan 10, 2024Sold 31,614 shares at $13.65 of Amicus Therapeutics¹³
Jan 9, 2024Shares withheld for tax 36,865 shares at $13.65 of Amicus Therapeutics¹²
Jan 9, 2024Granted 57,620 shares of Amicus Therapeutics¹²
Jan 9, 2024Shares withheld for tax 36,865 shares at $13.65 of Amicus Therapeutics¹³
Jan 4, 2024Shares withheld for tax 10,659 shares at $13.44 of Amicus Therapeutics¹⁴
Jan 3, 2024Shares withheld for tax 108,417 shares at $13.53 of Amicus Therapeutics¹⁵
Jan 2, 2024Granted 144,628 shares of Amicus Therapeutics¹⁵
Dec 18, 2023Granted 34,572 shares of Amicus Therapeutics¹⁶
Dec 15, 2023Sold 6,043 shares at $12.66 of Amicus Therapeutics¹⁶
Dec 1, 2023Sold 6,043 shares at $11.08 of Amicus Therapeutics¹⁷
Nov 15, 2023Sold 6,043 shares at $10.84 of Amicus Therapeutics¹⁸
Nov 1, 2023Sold 6,044 shares at $10.97 of Amicus Therapeutics¹⁹
Oct 16, 2023Sold 6,044 shares at $10.50 of Amicus Therapeutics²⁰
Oct 2, 2023Sold 1,600 shares at $11.71 of Amicus Therapeutics²¹
Oct 2, 2023Sold 4,444 shares at $11.08 of Amicus Therapeutics²¹
Sep 15, 2023Sold 6,044 shares at $13.06 of Amicus Therapeutics²²
Sep 1, 2023Sold 6,044 shares at $12.98 of Amicus Therapeutics²³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAmicus Therapeutics, Chair
2
SEC EDGARIntellia Therapeutics, Board member
3
SEC EDGAREntrada Therapeutics, Inc., Board member
4
SEC EDGARAmicus Therapeutics, Chief executive officer
5
SEC EDGAREntrada Therapeutics, Inc. shares after the filing of Jan 13, 2022
6
SEC EDGARIntellia Therapeutics shares after the filing of Jun 14, 2023
7
SEC EDGARAmicus Therapeutics shares after the filing of Mar 5, 2024
8
SEC EDGARForm 4 filed Feb 20, 2024
9
SEC EDGARForm 4 filed Feb 5, 2024
10
SEC EDGARForm 4 filed Jan 24, 2024
11
SEC EDGARForm 4 filed Jan 18, 2024
12
SEC EDGARForm 4 filed Mar 15, 2024
13
SEC EDGARForm 4 filed Jan 11, 2024
14
SEC EDGARForm 4 filed Jan 5, 2024
15
SEC EDGARForm 4 filed Jan 4, 2024
16
SEC EDGARForm 4 filed Dec 19, 2023
17
SEC EDGARForm 4 filed Dec 5, 2023
18
SEC EDGARForm 4 filed Nov 17, 2023
19
SEC EDGARForm 4 filed Nov 3, 2023
20
SEC EDGARForm 4 filed Oct 18, 2023
21
SEC EDGARForm 4 filed Oct 4, 2023
22
SEC EDGARForm 4 filed Sep 18, 2023
23
SEC EDGARForm 4 filed Sep 6, 2023